UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy

Annals of surgery, 2008-10, Vol.248 (4), p.564-577

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients

Transplantation, 2014-03, Vol.97 (6), p.636

2014

Link zum Volltext

Verfügbarkeit prüfen

One‐Year Results with Extended‐Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients

American journal of transplantation, 2007-03, Vol.7 (3), p.595-608

2007

Link zum Volltext

Verfügbarkeit prüfen

The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement

American journal of transplantation, 2019-03, Vol.19 (3), p.625-632

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients

Clinical transplantation, 2016-08, Vol.30 (8), p.901-911

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy

Transplantation, 2010-10, Vol.90 (8), p.891

2010

Link zum Volltext

Verfügbarkeit prüfen

Forty-Year Survival of Simultaneous Kidney and Duct-Injected Segmental Pancreas Transplants in a Recipient Maintained on Low-Dose Azathioprine and Prednisone

Transplantation proceedings, 2022-01, Vol.54 (1), p.104-106

2022

Link zum Volltext

Verfügbarkeit prüfen

Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients

Transplantation, 2007-06, Vol.83 (12), p.1648

2007

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab Induction in Renal Transplantation

The New England journal of medicine, 2011-05, Vol.364 (20), p.1909-1919

2011

Link zum Volltext

Verfügbarkeit prüfen

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study

Gastroenterology (New York, N.Y. 1943), 2021-07, Vol.161 (1), p.66-80.e8

2021

Link zum Volltext

Verfügbarkeit prüfen

Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal

Transplantation, 2013-02, Vol.95 (4), p.573

2013

Link zum Volltext

Verfügbarkeit prüfen

Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study

Transplantation, 2008-05, Vol.85 (9), p.1261

2008

Link zum Volltext

Verfügbarkeit prüfen

Kidney Graft Surveillance Biopsy Utilization and Trends: Results From a Survey of High-Volume Transplant Centers

Transplantation proceedings, 2020-12, Vol.52 (10), p.3085-3089

2020

Link zum Volltext

Verfügbarkeit prüfen

Multivariate Analysis of Risk Factors for Acute Rejection in Early Corticosteroid Cessation Regimens Under Modern Immunosuppression

American journal of transplantation, 2005-11, Vol.5 (11), p.2740-2744

2005

Link zum Volltext

Verfügbarkeit prüfen

Avoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real‐life scenario

Clinical transplantation, 2021-01, Vol.35 (1), p.e14145-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients

Transplantation, 2007-06, Vol.83 (12), p.1639

2007

Link zum Volltext

Verfügbarkeit prüfen

First clinical experience with the new once-daily formulation of tacrolimus

Therapeutic drug monitoring, 2008-04, Vol.30 (2), p.159

First, M Roy

2008

Link zum Volltext

Verfügbarkeit prüfen

Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results

Transplantation, 2008-07, Vol.86 (1), p.88

2008

Link zum Volltext

Verfügbarkeit prüfen

New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials

Transplantation, 2013-07, Vol.96 (1), p.58

2013

Link zum Volltext

Verfügbarkeit prüfen

De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population

Transplantation, 2009-05, Vol.87 (9), p.1347

2009

Link zum Volltext

Verfügbarkeit prüfen

Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression

Transplantation, 2005-07, Vol.80 (1), p.26

2005

Link zum Volltext

Verfügbarkeit prüfen

Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study

Clinical transplantation, 2005-02, Vol.19 (1), p.102-109

2005

Link zum Volltext

Verfügbarkeit prüfen

Serial Peripheral Blood Gene Expression Profiling to Assess Immune Quiescence in Kidney Transplant Recipients with Stable Renal Function

Annals of transplantation, 2020-04, Vol.25, p.e920839-e920839-7

2020

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-2 receptor antagonist therapy leads to increased tacrolimus levels after kidney transplantation

Therapeutic drug monitoring, 2015-04, Vol.37 (2), p.206

2015

Link zum Volltext

Verfügbarkeit prüfen

Renal function as a predictor of long‐term graft survival in renal transplant patients

Nephrology, dialysis, transplantation, 2003-05, Vol.18 (suppl-1), p.i3-i6

First, M Roy

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(176)
Science & Technology
(162)
Life Sciences & Biomedicine
(161)
Biological And Medical Sciences
(109)
Medical Sciences
(109)
Transplantation
(101)
Surgery
(97)
Adult
(91)
Male
(91)
Female
(83)
Kidney Transplantation
(74)
Immunology
(69)
Middle Aged
(66)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(60)
Immunosuppressive Agents - Therapeutic Use
(45)
Pharmacology. Drug Treatments
(40)
Surgery Of The Urinary System
(35)
Kidney Transplantation - Immunology
(34)
Immunomodulators
(29)
Urology & Nephrology
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy

Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients

One‐Year Results with Extended‐Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients

The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement

Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients

Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy

Forty-Year Survival of Simultaneous Kidney and Duct-Injected Segmental Pancreas Transplants in a Recipient Maintained on Low-Dose Azathioprine and Prednisone

Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients

Alemtuzumab Induction in Renal Transplantation

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study

Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal

Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study

Kidney Graft Surveillance Biopsy Utilization and Trends: Results From a Survey of High-Volume Transplant Centers

Multivariate Analysis of Risk Factors for Acute Rejection in Early Corticosteroid Cessation Regimens Under Modern Immunosuppression

Avoiding surveillance biopsy: Use of a noninvasive biomarker assay in a real‐life scenario

Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients

First clinical experience with the new once-daily formulation of tacrolimus

Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results

New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials

De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population

Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression

Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study

Serial Peripheral Blood Gene Expression Profiling to Assess Immune Quiescence in Kidney Transplant Recipients with Stable Renal Function

Interleukin-2 receptor antagonist therapy leads to increased tacrolimus levels after kidney transplantation

Renal function as a predictor of long‐term graft survival in renal transplant patients

Suchergebnisse filtern